Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

Our New Resource Page for Inflammatory Myofibroblastic Tumour

Become part of our growing rare cancer community.
Join our Facebook support group

Join Now

Posted by fatima.shakeel@opmc.co | Nov 11, 2024

An Inflammatory myofibroblastic tumour (IMT) is a rare growth that can develop in various parts of the body, commonly in the lungs, abdomen, pelvis, and soft tissues. IMTs are made up of myofibroblasts (cells involved in tissue repair) and inflammatory cells. While typically benign, some IMTs can behave aggressively, with a risk of recurrence or spread to other areas.

Many sufferers of Inflammatory Myofibroblastic Tumour struggle because they feel that their disease doesn’t have the same level of awareness as more common cancers. Without a Ribbon is an Australian non-profit organisation that believes that rare cancers should never go unnoticed. We aim to provide a detailed set of resources and information for anyone suffering from cancers such as Inflammatory Myofibroblastic Tumour. We have recently created an Inflammatory Myofibroblastic Tumour resource page to help sufferers understand their disease. It covers the symptoms, available treatments and other important information.

We hope that this resource page will help you or a friend/family member to learn about their illness and aid them through their battle with the disease.

If you want to help make a difference for sufferers of Inflammatory Myofibroblastic Tumour, click here to learn how you can help!

Click the link below to read our resource page on Inflammatory Myofibroblastic Tumour:

 

View Inflammatory Myofibroblastic Tumour Resource Page

Share:

PreviousInflammatory Myofibroblastic Tumour
NextCarcinoid Tumour of the Cervix

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter